MEI Pharma Buys $100M in Litecoin as Falling Wedge Hints at 58% Breakout

Aug. 7 — NASDAQ-listed biotech firm MEI Pharma has added $100 million worth of Litecoin (LTC) to its corporate treasury, making it the first publicly traded US company to adopt LTC as a reserve asset. The company confirmed the move on Wednesday, stating it acquired approximately 929,548 LTC in collaboration with Litecoin founder Charlie Lee […]

The post MEI Pharma Buys $100M in Litecoin as Falling Wedge Hints at 58% Breakout appeared first on CoinChapter.